Epicatechin ((-)-Epicatechin · Flavan-3-ol · Endothelial · Cardioprotective)

Compound	(-)-Epicatechin ((-)-3,3′,4′,5,7-Pentahydroxyflavane; Epicatechin)
Chemical class	Polyphenol — Flavan-3-ol (C-3 epimer of catechin; primary cocoa flavan-3-ol)
CAS	490-46-0
Primary source	Theobroma cacao (cocoa seeds), Camellia sinensis (green tea), Malus domestica (apple skin)
Key applications	Endothelial function; cardioprotective; NO-mediated vasodilation; muscle performance
Claim strength	Moderate to High
Typical form	Cocoa Extract Polyphenols 12% (Theobroma cacao; epicatechin as dominant flavan-3-ol); Green Tea Catechin Concentrate
Buy from Herbuno	Polyphenols 12% Powder (Cocoa Extract) | Standardized Theobroma cacao → Polyphenols 10% Powder (Cocoa Extract) | Standardized Theobroma cacao →

Name origin: Epicatechin is the C-3 epimer of catechin — the "epi-" prefix denoting the different configuration at C-3 of the flavan-3-ol C-ring. (-)-Epicatechin (2R,3R configuration) is the primary flavan-3-ol of Theobroma cacao — present in dark chocolate and cocoa at 5–10 mg per gram of dark chocolate — and is the structural unit for most proanthocyanidin polymers in cocoa and grape. Traditional use: Cacao (Theobroma cacao — "food of the gods") has been consumed in Mesoamerican cultures since at least 1900 BCE — first as a ceremonial drink (frothy unsweetened xocolatl mixed with chilli and vanilla) by the Olmec, Maya, and Aztec civilisations. Cacao was introduced to Europe by Spanish conquistadors and became a luxury food with attributed medicinal properties. Modern isolation of epicatechin and demonstration of its vasodilatory properties provided mechanistic grounding for historical observations of cardiovascular benefits in cocoa-consuming populations. Research trajectory: Epicatechin is among the most clinically studied individual flavonoids for cardiovascular outcomes. The Kuna indigenous people of Panama — who consume large amounts of flavanol-rich cocoa as their primary daily beverage and have remarkably low rates of hypertension and cardiovascular disease despite other risk factors — provided epidemiological motivation for a sustained body of flavanol RCTs. The COSMOS-Heart trial (2022, American Journal of Clinical Nutrition, n=21,442 — the largest flavanol cardiovascular RCT) showed cocoa flavanol supplementation significantly reduced cardiovascular disease events. Epicatechin is the primary flavanol responsible. Commercial source: Epicatechin is available from Herbuno via Cocoa Extract Polyphenols 12% and Cocoa Extract Polyphenols 10% (both standardised Theobroma cacao), delivering epicatechin as the dominant flavan-3-ol alongside procyanidin B2 and other cocoa polyphenols.

---

Evidence for Epicatechin Applications

Endothelial function and NO-mediated vasodilation: Epicatechin activates eNOS (endothelial nitric oxide synthase) in vascular endothelial cells via PI3K/Akt pathway phosphorylation — increasing NO production and promoting vasodilation. This mechanism is well-replicated across cell, animal, and human studies. Multiple RCTs demonstrate improved flow-mediated dilation (FMD) after cocoa flavanol ingestion (400–900 mg total flavanols), with effects appearing within 2 hours of consumption. The COSMOS-Heart trial (n=21,442, 3.6 years) showed 16% reduction in major adverse cardiovascular events with cocoa flavanol supplementation. Claim strength: High.

Blood pressure reduction: A Cochrane systematic review (2012, 20 trials, n=856) and subsequent meta-analyses demonstrate statistically significant reductions in systolic (2–5 mmHg) and diastolic (1–3 mmHg) blood pressure from cocoa flavanol supplementation in hypertensive and pre-hypertensive individuals. The effect size is modest but clinically meaningful at population level. Claim strength: High.

Muscle performance and exercise recovery: Epicatechin has an unusual mechanism in skeletal muscle — inhibiting myostatin (a negative regulator of muscle growth) and activating follistatin, promoting satellite cell differentiation and muscle protein accretion. This muscle-anabolic mechanism is distinct from typical sports nutrition ingredients. In small human studies, epicatechin supplementation (50–100 mg/day) improved grip strength and hand-to-forearm muscle ratio in community-dwelling older adults and enhanced VO₂max in trained cyclists. Claim strength: Moderate.

Cognitive and neuroprotective: Flavanol-rich cocoa consumption improves cognitive performance in older adults in multiple RCTs (including the COSMOS-Mind substudy showing 31% slower cognitive ageing equivalent in the highest-adherence group). Epicatechin and its metabolites (particularly epicatechin-γ-valerolactone from colonic fermentation) modulate cerebral blood flow via eNOS and cross the BBB at modest concentrations. Claim strength: Moderate.

---

Dosage & Formulator Specification

The cardiovascular RCT evidence base for cocoa flavanols used doses of 400–900 mg/day total flavanols (measuring epicatechin + catechin + procyanidin B2 combined). Isolated epicatechin studies for muscle performance used 50–100 mg/day over 4–12 weeks. For endothelial function, even single doses of 200–400 mg total cocoa flavanols show acute FMD improvement, with chronic supplementation providing sustained improvement.

For formulator specification: Cocoa Extract Polyphenols 12% from Herbuno provides approximately 8–10% epicatechin alongside procyanidin B2 and other polyphenols per gram of extract. At 500 mg serving, this delivers ~40–50 mg epicatechin — in the range of muscle performance study doses. For cardiovascular dosing (400+ mg total flavanols per serving), higher-extract or higher-serving formulations are needed.

Epicatechin stability in formulations is the critical quality parameter: the catechol B-ring is susceptible to oxidation (browning), particularly at alkaline pH, elevated temperature, and in the presence of transition metals. pH 4–6 aqueous formulations, nitrogen fill, antioxidant co-formulation (ascorbic acid, tocopherols), and metal ion chelation (EDTA, phytate) protect epicatechin content during manufacturing and shelf life. Dark (opaque) packaging is recommended.

Epicatechin's iron chelation reduces non-haem iron absorption when taken with iron-rich foods — relevant for iron-deficient populations. No other clinically significant drug interactions are established. Epicatechin inhibits CYP1A2 in vitro; clinical significance at supplement doses is not established but warrants awareness in patients on theophylline, clozapine, or other CYP1A2-narrow-window drugs.

---

Frequently Asked Questions — Epicatechin

What was the COSMOS-Heart trial and what did it show for cocoa flavanols?
COSMOS-Heart (Cocoa Supplement and Multivitamin Outcomes Study — Heart) was a randomised, double-blind, placebo-controlled trial of 21,442 US adults ≥60 years (men) or ≥65 years (women) supplemented with 500 mg/day cocoa flavanol extract (providing ~400 mg total flavanols, primarily epicatechin) or placebo over 3.6 years. The intervention group showed a statistically significant 16% reduction in major adverse cardiovascular events (MACE: heart attack, stroke, cardiovascular death) versus placebo — the largest cardiovascular benefit shown for a natural compound in a rigorous large-scale RCT to date.

How does epicatechin's myostatin inhibition mechanism work?
Myostatin (GDF-8) is a TGF-β family protein that limits skeletal muscle growth by inhibiting satellite cell activation and protein synthesis. Epicatechin reduces myostatin expression and promotes follistatin (the endogenous myostatin antagonist), shifting the myostatin/follistatin ratio toward anabolic status. This mechanism is pharmacologically convergent with the anti-myostatin drugs being developed for muscular dystrophy; epicatechin achieves it at a modest nutritional level. Small human studies show grip strength improvement in older adults after 3 months of epicatechin supplementation.

How does epicatechin from cocoa compare to that from green tea?
Structurally identical — (-)-epicatechin is the same molecule regardless of source. The difference lies in the accompanying flavonoid matrix: cocoa delivers epicatechin primarily alongside procyanidin B2 and other oligomers, with minimal EGCG; green tea delivers epicatechin alongside EGCG, EGC, and catechin. The cardiovascular evidence base is stronger for cocoa epicatechin (including COSMOS-Heart); the metabolic and thermogenic evidence is stronger for green tea's EGCG-dominant catechin profile. For pure epicatechin delivery, cocoa extract is the preferred source.

What is the Kuna cocoa connection in cardiovascular research?
The Kuna indigenous people of San Blas islands (Panama) drink 5+ cups of minimally processed, flavanol-rich cocoa daily and have remarkably low blood pressure, minimal age-related hypertension rise, and very low cardiovascular disease rates — despite salt intake and obesity prevalence that would predict high CVD risk by standard epidemiological models. When Kuna migrate to Panama City and switch to commercial cocoa, these benefits disappear. This natural experiment (studied by Norman Hollenberg at Harvard) provided compelling observational motivation for the subsequent decades of cocoa flavanol RCTs and mechanistic studies.

Related compounds: Catechin, EGCG, Procyanidin B2, Taxifolin

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery